Cambridge Investment Research Advisors’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,362
| Closed | -$339K | – | 3325 |
|
|
2023
Q3 | $339K | Sell |
21,362
-2,071
| -9% | -$32.9K | ﹤0.01% | 2411 |
|
|
2023
Q2 | $442K | Sell |
23,433
-27,968
| -54% | -$528K | ﹤0.01% | 2228 |
|
|
2023
Q1 | $197K | Buy |
51,401
+636
| +1% | +$2.44K | ﹤0.01% | 2836 |
|
|
2022
Q4 | $252K | Sell |
50,765
-2,698
| -5% | -$13.4K | ﹤0.01% | 2568 |
|
|
2022
Q3 | $256K | Sell |
53,463
-100
| -0.2% | -$479 | ﹤0.01% | 2498 |
|
|
2022
Q2 | $241K | Buy |
53,563
+25,589
| +91% | +$115K | ﹤0.01% | 2570 |
|
|
2022
Q1 | $133K | Buy |
27,974
+99
| +0.4% | +$471 | ﹤0.01% | 2969 |
|
|
2021
Q4 | $207K | Buy |
27,875
+9,188
| +49% | +$68.2K | ﹤0.01% | 2869 |
|
|
2021
Q3 | $106K | Buy |
+18,687
| New | +$106K | ﹤0.01% | 2947 |
|
|
2021
Q1 | – | Sell |
-17,373
| Closed | -$112K | – | 3012 |
|
|
2020
Q4 | $112K | Sell |
17,373
-2,493
| -13% | -$16.1K | ﹤0.01% | 2586 |
|
|
2020
Q3 | $72K | Buy |
19,866
+100
| +0.5% | +$362 | ﹤0.01% | 2425 |
|
|
2020
Q2 | $91K | Hold |
19,766
| – | – | ﹤0.01% | 2326 |
|
|
2020
Q1 | $67K | Buy |
+19,766
| New | +$67K | ﹤0.01% | 2161 |
|
|
2014
Q2 | – | Sell |
-18,358
| Closed | -$274K | – | 1379 |
|
|
2014
Q1 | $274K | Buy |
18,358
+2,950
| +19% | +$44K | 0.01% | 995 |
|
|
2013
Q4 | $226K | Buy |
15,408
+700
| +5% | +$10.3K | 0.01% | 1016 |
|
|
2013
Q3 | $250K | Buy |
14,708
+800
| +6% | +$13.6K | 0.01% | 938 |
|
|
2013
Q2 | $231K | Buy |
+13,908
| New | +$231K | 0.01% | 879 |
|